Literature DB >> 16876208

Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.

Rachel Tomer1, Judith Aharon-Peretz, Zina Tsitrinbaum.   

Abstract

Contradictory evidence exists regarding the nature and degree of impaired cognitive flexibility in PD. Dopaminergic medication may be expected to ameliorate such cognitive deficits, yet both medicated and unmedicated patients have been reported to perform more poorly than control subjects on tasks of cognitive flexibility, suggesting that such deficits may also be affected by other disease-related variables. The present study examined whether asymmetric dopamine deficiency (revealed by unilateral symptom onset) is related to the performance of spontaneous and reactive flexibility in PD, and the possible interaction of dopaminergic medication with such asymmetry. Thirty-five PD patients with mild motor symptoms and unilateral onset of PD (left-onset=14; right-onset=21) performed the Alternate Uses (AU) and intradimensional/extradimensional shift (IED) tasks. Interaction between side of onset and medication was observed for the number of errors in the AU task and number of reversal errors in the IED task. Significantly more AU errors were made by medicated patients with left-onset, as compared to all other participants. Conversely, medicated patients with right-onset made the most reversal errors. These results suggest that relatively early in the disease process when dopamine deficit in the less-affected hemisphere is mild, optimal dopaminergic medication (with respect to motor function) may involve over-medication of the less-affected hemisphere. Thus, AU errors may be the consequence of hyperdopaminergic state leading to impaired functioning of the left hemisphere, whereas increased reversal errors in right-onset PD patients receiving dopaminergic medication is related to impaired dopamine function in the right hemisphere.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876208     DOI: 10.1016/j.neuropsychologia.2006.06.014

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  12 in total

Review 1.  Cognitive differences between patients with left-sided and right-sided Parkinson's disease. A review.

Authors:  Nele Verreyt; Gudrun M S Nys; Patrick Santens; Guy Vingerhoets
Journal:  Neuropsychol Rev       Date:  2011-09-29       Impact factor: 7.444

2.  Striatal dopamine influences the default mode network to affect shifting between object features.

Authors:  Linh C Dang; Aneesh Donde; Cindee Madison; James P O'Neil; William J Jagust
Journal:  J Cogn Neurosci       Date:  2012-05-29       Impact factor: 3.225

Review 3.  Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.

Authors:  Alexander I Tröster
Journal:  Neuropsychol Rev       Date:  2008-03-06       Impact factor: 7.444

Review 4.  Rule-based category learning in patients with Parkinson's disease.

Authors:  Amanda Price; J Vincent Filoteo; W Todd Maddox
Journal:  Neuropsychologia       Date:  2009-02-02       Impact factor: 3.139

Review 5.  Mild cognitive impairment exists in Parkinson's disease.

Authors:  Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2011-06-19       Impact factor: 3.575

6.  Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.

Authors:  Brenda Hanna-Pladdy; Rajesh Pahwa; Kelly E Lyons
Journal:  J Int Neuropsychol Soc       Date:  2015-04-29       Impact factor: 2.892

7.  Cerebellar Modulation of Mesolimbic Dopamine Transmission Is Functionally Asymmetrical.

Authors:  Zade R Holloway; Nick B Paige; Josiah F Comstock; Hunter G Nolen; Helen J Sable; Deranda B Lester
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

8.  Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease.

Authors:  Erin R Foster; Kevin J Black; Jo Ann V Antenor-Dorsey; Joel S Perlmutter; Tamara Hershey
Journal:  Brain Cogn       Date:  2007-11-19       Impact factor: 2.310

9.  Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function.

Authors:  Penny A Macdonald; Oury Monchi
Journal:  Parkinsons Dis       Date:  2011-03-06

10.  Differential effects of Parkinson's disease and dopamine replacement on memory encoding and retrieval.

Authors:  Alex A MacDonald; Ken N Seergobin; Adrian M Owen; Ruzbeh Tamjeedi; Oury Monchi; Hooman Ganjavi; Penny A MacDonald
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.